American Journal of Epidemiology Advance Access originally published online on August 11, 2006
American Journal of Epidemiology 2006 164(10):998-1002; doi:10.1093/aje/kwj283
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contribution |
Serum Cholesterol Levels and the Risk of Parkinson's Disease
1 Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, the Netherlands
2 Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands
Correspondence to Dr. M. M. B. Breteler, Department of Epidemiology and Biostatistics, Erasmus Medical Center, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands (e-mail: m.breteler{at}erasmusmc.nl).
Several recent findings suggest a role of lipid and cholesterol metabolism in the pathogenesis of Parkinson's disease. Therefore, the authors examined the association between serum levels of cholesterol and the risk of Parkinson's disease in the prospective, population-based Rotterdam Study among 6,465 subjects aged 55 or more years with repeated in-person examination and on average 9.4 years of follow-up (1990–2004). Higher serum levels of total cholesterol were associated with a significantly decreased risk of Parkinson's disease (age- and sex-adjusted hazard ratio per mmol/liter increase in cholesterol = 0.77, 95% confidence interval: 0.64, 0.94), with evidence for a dose-effect relation. The association was restricted to women and remained unchanged after adjustment for multiple potential confounders. These findings may indicate a role of lipids in the pathogenesis of Parkinson's disease. Alternatively, they could reflect the strong correlation—especially in women—between levels of serum cholesterol and the antioxidant coenzyme Q10. If confirmed, this would provide further support for an important role of oxidative stress in the pathogenesis of Parkinson's disease.
cholesterol; cohort studies; lipid metabolism; neurodegenerative diseases; Parkinson disease; prospective studies; risk factors; serum
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Hu, R. Antikainen, P. Jousilahti, M. Kivipelto, and J. Tuomilehto Total cholesterol and the risk of Parkinson disease Neurology, May 20, 2008; 70(21): 1972 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Wahner, J. M. Bronstein, Y. M. Bordelon, and B. Ritz Statin use and the risk of Parkinson disease Neurology, April 15, 2008; 70(16_Part_2): 1418 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Becker, S. S. Jick, and C. R. Meier Use of antihypertensives and the risk of Parkinson disease Neurology, April 15, 2008; 70(16_Part_2): 1438 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Alonso, L. A. G. Rodriguez, G. Logroscino, and M. A. Hernan Gout and risk of Parkinson disease: A prospective study Neurology, October 23, 2007; 69(17): 1696 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Simon, H. Chen, M. Schwarzschild, and A. Ascherio Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease Neurology, October 23, 2007; 69(17): 1688 - 1695. [Abstract] [Full Text] [PDF]
|
|